pI: 10.8199 |
Length (AA): 315 |
MW (Da): 37727 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 229 | 4tql (A) | 31 | 221 | 32.00 | 0.11 | 0.31 | 0.667484 | 0.86 |
8 | 277 | 4hte (A) | 261 | 546 | 23.00 | 0.81 | 0.66 | 0.847643 | 1.21 |
98 | 279 | 4uos (A) | 2 | 184 | 19.00 | 0.061 | 0.04 | 0.753178 | -0.78 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, merozoite, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 24 hs, sporozoite, early ring, early trophozoite, late ring, late trophozoite, Ring, Sporozoite, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | early schizont. | PlasmoDB |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_128088)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G22660 | putative rRNA-processing protein EBP2-like protein |
Babesia bovis | BBOV_I002800 | conserved hypothetical protein |
Brugia malayi | Bm1_43510 | Probable rRNA processing protein EBP2 homolog |
Candida albicans | CaO19.11968 | similar to S. cerevisiae EBP2 (YKL172W) nucleolar protein required for pre-rRNA processing |
Candida albicans | CaO19.4492 | similar to S. cerevisiae EBP2 (YKL172W) nucleolar protein required for pre-rRNA processing |
Caenorhabditis elegans | CELE_C18A3.3 | Protein C18A3.3 |
Cryptosporidium hominis | Chro.60398 | hypothetical protein |
Cryptosporidium parvum | cgd6_3450 | EBNA1 binding protein 2; nucleolar protein p40 |
Dictyostelium discoideum | DDB_G0284817 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1542 | CG1542 gene product from transcript CG1542-RA |
Echinococcus granulosus | EgrG_000413400 | rRNA processing protein EBP2 |
Entamoeba histolytica | EHI_055830 | rRNA processing protein, putative |
Entamoeba histolytica | EHI_179050 | rRNA processing protein, putative |
Echinococcus multilocularis | EmuJ_000413400 | rRNA processing protein EBP2 |
Giardia lamblia | GL50803_10810 | Hypothetical protein |
Homo sapiens | ENSG00000117395 | EBNA1 binding protein 2 |
Leishmania braziliensis | LbrM.34.1730 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_351810.1 | Eukaryotic rRNA processing protein EBP2, putative |
Leishmania infantum | LinJ.35.1810 | hypothetical protein, conserved |
Leishmania major | LmjF.35.1820 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.1820 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_03513 | hypothetical protein |
Mus musculus | ENSMUSG00000028729 | EBNA1 binding protein 2 |
Neospora caninum | NCLIV_063500 | hypothetical protein, conserved |
Oryza sativa | 4343215 | Os07g0475800 |
Plasmodium berghei | PBANKA_0512400 | rRNA-processing protein EBP2, putative |
Plasmodium falciparum | PF3D7_1028300 | rRNA-processing protein EBP2, putative |
Plasmodium knowlesi | PKNH_0612700 | rRNA-processing protein EBP2, putative |
Plasmodium vivax | PVX_111305 | rRNA-processing protein EBP2, putative |
Plasmodium yoelii | PY05509 | hypothetical protein |
Saccharomyces cerevisiae | YKL172W | Ebp2p |
Schistosoma japonicum | Sjp_0217910 | Probable rRNA-processing protein EBP2, putative |
Schistosoma japonicum | Sjp_0101950 | expressed protein |
Schistosoma mansoni | Smp_160420 | rRNA processing protein ebna1-binding protein-related |
Schmidtea mediterranea | mk4.001683.03 | Probable rRNA-processing protein EBP2 homolog |
Trypanosoma brucei gambiense | Tbg972.9.9320 | rRNA processing protein, putative |
Trypanosoma brucei | Tb927.9.15060 | rRNA processing protein, putative |
Trypanosoma congolense | TcIL3000_9_6280 | rRNA processing protein, putative |
Trypanosoma cruzi | TcCLB.510763.109 | rRNA processing protein, putative |
Trypanosoma cruzi | TcCLB.509671.120 | rRNA processing protein, putative |
Toxoplasma gondii | TGME49_246730 | hypothetical protein |
Theileria parva | TP01_0567 | hypothetical protein |
Trichomonas vaginalis | TVAG_047230 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_467310 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.244.2790 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.244.2790 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.244.2790 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.244.2790 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C18A3.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C18A3.3 | Caenorhabditis elegans | larval arrest | wormbase |
YKL172W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_246730 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Influenza A virus (strain A/Wilson-Smith/1933 H1N1) | Nucleoprotein | Compounds | References |
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Pfal005664; Recombinant protein: full-length; Source: P falciparum; hypothetical protein, conserved ; |